Branched polyethylene glycol for linking polymer residues to antibodies
Details for Australian Patent Application No. 2004305291 (hide)
International Classifications
Event Publications
13 July 2006 PCT application entered the National Phase
PCT publication WO2005/061005 Priority application(s): WO2005/061005
14 February 2008 Assignment before Grant
Celltech R&D Limited The application has been assigned to UCB Pharma S.A. 2005
24 June 2010 Application Accepted
Published as AU-B-2004305291
21 October 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004305293-Process for producing pellets for pharmaceutical compositions
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser